The transcription factor TOX is well studied in the context of CD8⁺ T cell functionality, but less is known about its role in CD4⁺ T cells. Here the authors show that TOX drives TH1 cell differentiation and effector function that can drive antitumor immunity and autoimmune pathology.
- Brianna Naizir
- Andrew C. Scott
- Andrea Schietinger